Fig. 2From: A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort studyROC curve of APRI, FIB-4, CD4/APRI, and CD4/FIB-4. AUC of ROC curves corresponding to CD4/FIB-4 ratio is 0.716. Other AUC data results are shown in Table 2Back to article page